Results 221 to 230 of about 7,029,797 (363)

Observations on a growth factor for Leuconostoc citrovorum [PDF]

, 1950
W. B. Emery, K. A. Lees, A. D. Walker
openalex   +1 more source

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

Molecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková, Marie Ehrlichová, Alžběta Spálenková, Ivona Krus, Simona Šůsová, Viktor Hlaváč, Vlasta Němcová, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Soňa Měšťáková, Pavel Souček   +14 more
wiley   +1 more source

Vascular endothelial growth factor: a key factor in the onset and treatment of depression. [PDF]

Front Cell Neurosci
Wang J, Meng F, Wang L, Li Z.
europepmc   +1 more source

THE ABSENCE FROM THE URINE OF PERNICIOUS ANEMIA PATIENTS OF A MOSQUITO GROWTH FACTOR PRESENT IN NORMAL URINE [PDF]

, 1938
W. Trager, D Miller, C. P. Rhoads
openalex   +1 more source

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

Molecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim, Sungwoo Bae, Jaeyong Choi, Sun‐Wha Im, Bukyoung Cha, Gyeongseo Jung, Sun Wook Cho, Eul‐Ju Seo, Young Ah Lee, Jin Chul Paeng, Young Joo Park, Jong‐Il Kim   +11 more
wiley   +1 more source

New Experimental Mouse Models to Evaluate the Role of Transforming Growth Factor-Beta in Liver Tumorigenesis. [PDF]

Liver Int
Cantos-Cortes A, Amengual J, Espinosa-Sotelo R, Bertran E, Vaquero J, de Galarreta MR, Molina-Sanchez P, Serrano T, Ramos E, Calvo M, Scialpi R, Dituri F, Giannelli G, Lujambio A, Gonzalez-Sanchez E, Fabregat I.   +15 more
europepmc   +1 more source

Chick Growth Depressing Factor in Sun-Cured and Dehydrated Alfalfa Meals

, 1951
Rudolph Kodras, W. T. Cooney, J. S. Butts   +2 more
openalex   +1 more source

FACTORS INFLUENCING THE GROWTH OF SHIGELLA DYSENTERIAE 1 IN A SYNTHETIC MEDIUM [PDF]

, 1954
Richard B. Johnson
openalex   +1 more source

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

Molecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez, Asieh Naderi, Kim‐Tuyen Huynh‐Dam, Vitali Sikirzhytski, Ioulia Chatzistamou, Hippokratis Kiaris   +5 more
wiley   +1 more source

The amphiregulin- epidermal growth factor receptor axis as a therapeutic target in sepsis. [PDF]

Front Immunol
Walsh R, Snow TAC, Martinez AZ, Brealey D, Singer M, Das A, Arulkumaran N, University College London Hospitals Critical Care Research Team.   +7 more
europepmc   +1 more source